Hepsera and Appetite - decreased - a phase IV clinical study of FDA data

Summary:

Appetite - decreased is reported as a side effect among people who take Hepsera (adefovir dipivoxil), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Viread, and have Pain.

The phase IV clinical study analyzes which people have Appetite - decreased when taking Hepsera. It is created by eHealthMe based on reports of 3,102 people who have side effects when taking Hepsera from the FDA, and is updated regularly.

What is Hepsera?

Hepsera has active ingredients of adefovir dipivoxil. It is often used in hepatitis b. eHealthMe is studying from 3,113 Hepsera users. Check the latest studies of Hepsera.

What is Appetite - decreased?

Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,629 drugs and 4,579 conditions by eHealthMe. Check the latest studies of Appetite - decreased.

On May, 22, 2026

3,102 people reported to have side effects when taking Hepsera.
Among them, 33 people (1.06%) have Appetite - decreased.

Could Hepsera cause Appetite - decreased?

Among these 33 people:

How long have people been on Hepsera when they have Appetite - decreased? *

What is the gender of people who have Appetite - decreased when taking Hepsera? *

female: 32.26 %
male: 67.74 %

What is the age of people who have Appetite - decreased when taking Hepsera? *

What are other drugs people take besides Hepsera? *

What are other side effects people have besides Appetite - decreased? *

Nausea (feeling of having an urge to vomit): 12 people, 36.36%
Nausea And Vomiting: 9 people, 27.27%
Abdominal Discomfort: 8 people, 24.24%
Fanconi Syndrome Acquired (self developed genetic disease of kidney damage due to defective transport system): 8 people, 24.24%
Fatigue (feeling of tiredness): 8 people, 24.24%
Hypokalemia (low potassium): 7 people, 21.21%
Weight Decreased: 7 people, 21.21%
Hepatic Function Abnormal: 7 people, 21.21%
Hepatic Failure (liver failure): 7 people, 21.21%
Fever: 7 people, 21.21%

What are the existing conditions these people have? *

Pain: 9 people, 27.27%
Hepatic Neoplasm Malignant (liver cancer): 5 people, 15.15%
Hiv Infection: 2 people, 6.06%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 6.06%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 6.06%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.03%
Metastases To Bone (cancer spreads to bone): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Hepsera and have Appetite - decreased?

- Check whether Appetite - decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hepsera:

Hepsera (3,113 reports)

Browse all side effects of Hepsera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - decreased:

Appetite - decreased (3,629 drugs)

Browse all the conditions that are associated with Appetite - decreased:

Appetite - decreased (4,579 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on adefovir dipivoxil (the active ingredients of Hepsera) and Hepsera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.